Trial Details
WITHDRAWNBasic Information
| Clinical ID | c3260 |
|---|---|
| Identifier | NCT02320318 |
| Trial Title | 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: Ibodutant 10 mg|DRUG: Placebo |
Participant Information
| Sponsor | Menarini Group |
|---|---|
| City | Singapore |
| Country/Region | Singapore |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2015-10 |
|---|---|
| Primary Completion Date | 2016-12 |
| Completion Date | 2016-12 |